title: Phase II study of ifosfamide (Holoxan) in hepatoma.
authors.affiliation: Department of Internal Medicine, Chiang Mai University, Thailand.
authors.forename: S
authors.initials: S
authors.lastname: Thongprasert
authors.forename: K
authors.initials: K
authors.lastname: Klunklin
authors.forename: K
authors.initials: K
authors.lastname: Phornphutkul
authors.forename: O A
authors.initials: OA
authors.lastname: Prisontarangkul
authors.forename: B
authors.initials: B
authors.lastname: Chaimongkol
authors.forename: B
authors.initials: B
authors.lastname: Sivasomboon
mesh_terms: D000328:Adult; D006528:Carcinoma, Hepatocellular / Q000188:drug therapy*; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D007069:Ifosfamide / Q000627:therapeutic use*; D007958:Leukocyte Count; D008113:Liver Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male; D008875:Middle Aged; D010976:Platelet Count
chemical_list: D007069:Ifosfamide